Literature DB >> 24211232

Fluorescence in situ hybridization panel for monitoring of minimal residual disease in patients with double minute chromosomes.

Yongbum Jeon1, Seon Young Kim1, Miyoung Kim1, Hyun-Kyung Park2, Sang Ho Lee3, Cha Ja See3, Jiseok Kwon4, Dong Soon Lee5.   

Abstract

A double minute chromosome (dmin) is a small fragment of extrachromosomal DNA bearing amplified genes observed in malignancies. We investigated the incidence and characteristics of dmins in hematologic malignancies, and the quantitative changes during the treatment follow-up. Once a dmin was observed in conventional G-banding, it was characterized using fluorescence in situ hybridization (FISH) with the panel of MYC, NMYC, and MLL probes. Quantitative changes of malignant cells were measured using G-banding and FISH during the follow up. Dmins were observed in 1.23% of patients (6/489) at the initial diagnosis including 4 with MYC amplification, 1 with MLL and 1 with NMYC. All 6 had complex karyotypes and showed short overall survival (7.7 months). In follow-up specimens, FISH detected dmins in 11 cases out of which G-banding detected dmins in 9 cases. The number of dmins detected by FISH and G-banding did not correlate well. Amplification of NMYC in dmins is reported for the first time. A FISH panel composed of frequently amplified oncogenes (MYC, NMYC, and MLL) in dmins is useful for characterization of dmins. FISH is a sensitive method in detecting dmins and will be useful in monitoring of the minimal residual disease.
© 2013.

Entities:  

Keywords:  Double minute chromosome; Fluorescence in situ hybridization; NMYC; Oncogene

Mesh:

Substances:

Year:  2013        PMID: 24211232     DOI: 10.1016/j.bcmd.2013.10.008

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  3 in total

Review 1.  New insights of extrachromosomal DNA in tumorigenesis and therapeutic resistance of cancer.

Authors:  Hui Qiu; Zhi-Ying Shao; Xin Wen; Long-Zhen Zhang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

2.  [Amplification of Extrachromosomal Oncogene and Tumorigenesis and Development].

Authors:  Yutong Wang; Fan Ye; Xiao Zhang; Ruihan Zou; Mingyuan Wang; Kai Yu; Shiyun Cui
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-12-20

Review 3.  Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance.

Authors:  Yuanliang Yan; Guijie Guo; Jinzhou Huang; Ming Gao; Qian Zhu; Shuangshuang Zeng; Zhicheng Gong; Zhijie Xu
Journal:  J Hematol Oncol       Date:  2020-09-14       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.